CVS Health Corporation (CVS)

59.43
0.65 1.11
NYSE
Prev Close 58.78
Open 59.04
Day Low/High 58.46 / 59.87
52 Wk Low/High 52.04 / 77.03
Volume 7.53M
Exchange NYSE
Shares Outstanding 1308.70B
Market Cap 77.99B
P/E Ratio 9.47
Div & Yield N.A. (N.A)

Latest News

Jim Cramer: Better to Mask and Test Than Wait for Vaccine

Jim Cramer: Better to Mask and Test Than Wait for Vaccine

New rapid tests and the effectiveness of universal mask wearing give hope while we wait on the elusive vaccine.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

A Tale of Two Markets

A Tale of Two Markets

So, is this a good time, or a bad time to buy stocks? Yes, and yes.

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Jim Cramer: Abbott's Rapid Covid-19 Test and My Super Bowl Dreams

Abbott Labs can bring back some normalcy to this country -- and the world -- with its BinaxNOW rapid antigen test along with its amazing Navica app.

Refuse to Be Gaslighted by Market Pundits

Refuse to Be Gaslighted by Market Pundits

Follow fundamentals and ignore the attempts to gaslight you into not believing your own projections.

Get Your Portfolio Healthy with CVS

Get Your Portfolio Healthy with CVS

CVS has strong fundamentals, a good price, and plenty of room to catch up.

This Dividend Stock Is Just What the Doctor Ordered

This Dividend Stock Is Just What the Doctor Ordered

CVS is an undervalued health care stock with a solid dividend yield above 3%.

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

Parabolic AMD, Agreeing to Agree, Disney's GAAP Earnings Gap: Market Recon

It is going to take successful vaccines and therapies and much lower unemployment to revive most of Walt Disney Co.'s businesses.

Jim Cramer: We Have Underestimated Our Covid-19 Enemy

Jim Cramer: We Have Underestimated Our Covid-19 Enemy

Why aren't we figuring out how to cure the test bottleneck?

Jim Cramer: Let's Unmask the Anti-Mask Folks as Truly Un-American

Jim Cramer: Let's Unmask the Anti-Mask Folks as Truly Un-American

Even the president has switched sides on this issue that could help flatten the curve and help get the economy rolling again.

Let's Take Another Look at the Charts and Indicators of CVS Health

Let's Take Another Look at the Charts and Indicators of CVS Health

If you are long CVS continue to hold.

Jim Cramer: 'Excuse Selling'

Jim Cramer: 'Excuse Selling'

Let's go over five excuses so you know and are armed with them when they are used and make you faint and weak-handed.

Real Money Post Industrial Average Outperforms, Despite Outbreak

Real Money Post Industrial Average Outperforms, Despite Outbreak

The RMPIA rebounded more than 22% in the June quarter to finish up 7.8% at the 2020 half mark.

Is the Fed Going Out of (Yield Curve) Control?

Is the Fed Going Out of (Yield Curve) Control?

The Federal Reserve posted its June meeting minutes and a report on individual corporate bonds bought so far. Here's my take on both.

I Wouldn't Buy Pfizer Shares on This Pop

I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.

I've Got the Perfect Prescription for Your Portfolio

I've Got the Perfect Prescription for Your Portfolio

Here's how to play CVS Health and avoid most negative investing side effects.

Here's What Would Resume the Bull Case for CVS

Here's What Would Resume the Bull Case for CVS

After CVS released quarterly earnings and the CEO's appearance on 'Mad Money,' let's look at the charts for this health and pharmacy retailer.

CVS Health Reports and Here's How I'd Play It

CVS Health Reports and Here's How I'd Play It

CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.

Act Like a Trader, Digging Into Disney, a Name In the Clouds

Act Like a Trader, Digging Into Disney, a Name In the Clouds

Disney's trajectory could provide a blueprint for the reopening of travel and leisure -- and how investors react.

CVS Must Be Taking Its Own Medicine: It's Looking Healthy

CVS Must Be Taking Its Own Medicine: It's Looking Healthy

The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.

Deep in the Weeds of the Covid-19 Outbreak, Cannabis Cos. Adapt to Survive

Deep in the Weeds of the Covid-19 Outbreak, Cannabis Cos. Adapt to Survive

Some businesses offer curbside delivery while others boost online sales -- still some can't escape closings and cut forecasts.

CVS Health Could Soon Begin a Bottoming Process

CVS Health Could Soon Begin a Bottoming Process

Let's check and see if all their programs and initiatives could help the charts and indicators of CVS.

At This Point, It's Not Time to Buy

At This Point, It's Not Time to Buy

As I've stated before, I'm looking for names that are 'stupid cheap', and I'm not sure we're there yet.

Jim Cramer: These Two Qualities Are What Count in Retail Right Now

Jim Cramer: These Two Qualities Are What Count in Retail Right Now

It's online, off-price, or nothing in the time of the coronavirus.

Market Outflows, Unknown Earnings Expectations and Trading Notes: Market Recon

Market Outflows, Unknown Earnings Expectations and Trading Notes: Market Recon

Here are a number of things that I'm watching now.

Despite Virus Fears, Avoid Retail Pharmacy Stocks

Despite Virus Fears, Avoid Retail Pharmacy Stocks

With so many consumers preparing for a potential coronavirus outbreak, you might think that owning retail pharmacy stocks makes sense right now.